Your browser doesn't support javascript.
loading
Differences in systemic and mucosal SARS-CoV-2 antibody prevalence in a prospective cohort of Dutch children.
Keuning, Maya W; Grobben, Marloes; Bijlsma, Merijn W; Anker, Beau; Berman-de Jong, Eveline P; Cohen, Sophie; Felderhof, Mariet; de Groen, Anne-Elise; de Groof, Femke; Rijpert, Maarten; van Eijk, Hetty W M; Tejjani, Khadija; van Rijswijk, Jacqueline; Steenhuis, Maurice; Rispens, Theo; Plötz, Frans B; van Gils, Marit J; Pajkrt, Dasja.
Afiliação
  • Keuning MW; Department of Pediatric Infectious Diseases, Rheumatology & Immunology, Amsterdam University Medical Centers (UMC), location University of Amsterdam, Amsterdam, Netherlands.
  • Grobben M; Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam University Medical Centers (UMC) location University of Amsterdam, Amsterdam, Netherlands.
  • Bijlsma MW; Infectious diseases, Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands.
  • Anker B; Department of Pediatrics, Emma Children's Hospital Amsterdam University Medical Centers (UMC), University of Amsterdam, Amsterdam, Netherlands.
  • Berman-de Jong EP; Department of Pediatrics, Emma Children's Hospital Amsterdam University Medical Centers (UMC), University of Amsterdam, Amsterdam, Netherlands.
  • Cohen S; Department of Pediatrics, Emma Children's Hospital Amsterdam University Medical Centers (UMC), University of Amsterdam, Amsterdam, Netherlands.
  • Felderhof M; Department of Pediatrics, Emma Children's Hospital Amsterdam University Medical Centers (UMC), University of Amsterdam, Amsterdam, Netherlands.
  • de Groen AE; Department of Pediatrics, Flevoziekenhuis, Almere, Netherlands.
  • de Groof F; Department of Pediatric Infectious Diseases, Rheumatology & Immunology, Amsterdam University Medical Centers (UMC), location University of Amsterdam, Amsterdam, Netherlands.
  • Rijpert M; Department of Pediatrics, Noordwest Ziekenhuisgroep, Alkmaar, Netherlands.
  • van Eijk HWM; Department of Pediatrics, Zaans Medical Center, Zaandam, Netherlands.
  • Tejjani K; Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam University Medical Centers (UMC) location University of Amsterdam, Amsterdam, Netherlands.
  • van Rijswijk J; Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam University Medical Centers (UMC) location University of Amsterdam, Amsterdam, Netherlands.
  • Steenhuis M; Infectious diseases, Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands.
  • Rispens T; Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam University Medical Centers (UMC) location University of Amsterdam, Amsterdam, Netherlands.
  • Plötz FB; Infectious diseases, Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands.
  • van Gils MJ; Department of Immunopathology, Sanquin Research, Amsterdam, Netherlands.
  • Pajkrt D; Landsteiner Laboratory, Amsterdam University Medical Centers (UMC), University of Amsterdam, Amsterdam, Netherlands.
Front Immunol ; 13: 976382, 2022.
Article em En | MEDLINE | ID: mdl-36159841

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies Limite: Adult / Child / Female / Humans / Male Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies Limite: Adult / Child / Female / Humans / Male Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda